This medical reference app provides healthcare professionals and trainees with up-to-date information on diagnosing, treating, and preventing syphilis. It includes tools for screening, serologic testing, staging, treatment, monitoring, and partner management, all based on CDC guidelines.
1.1
September 13, 2026
App revised to fix two errors: Image for Traditional Algorithm replaced with correct image on 2 locations Title for Screening More Information corrected from About to More Information.
MoreWe appreciate the feedback. Thanks for letting us know about the bug in the Texas counties dropdown list! We're working on this now and will get the fix out in our next update.
Syphilis Tools is an educational reference application for healthcare providers, offering comprehensive information on diagnosing, treating, and preventing syphilis. It is based on CDC STI Treatment Guidelines and developed by the University of Washington.
Based on the provided data, Syphilis Tools is supported on iPhone, iPad, and iPod. Information regarding Android availability is not specified.
No, Syphilis Tools does not contain advertisements. The app is free to use and does not include any in-app purchases or ads.
The latest version, 1.1, was released on 2026-09-13, indicating recent updates. The app's content is based on CDC guidelines, which are periodically updated, suggesting the app may follow suit.
Key features include content directly from CDC STI Treatment Guidelines, offline accessibility, plain-text summaries, a Geographic Risk Tool, and a Nontreponemal Titer Tool for interpreting serologic results.
Syphilis Tools has an age rating of 17+. This is appropriate given the medical nature of the content, which is intended for healthcare professionals and trainees.
Yes, Syphilis Tools offers offline accessibility. This feature allows users to access its content and tools even in environments without an internet connection.
The app covers screening recommendations, serologic testing interpretation, staging criteria, treatment regimens, monitoring of serologic response, and partner management guidance for syphilis.
